Why the study?
Does sirolimus eluting stent implantation reduce major adverse cardiac events in patients with multivessel disease compared to bare metal stents?
Does sirolimus eluting stent implantation reduce major adverse cardiac events in patients with multivessel disease compared to bare metal stents?
Answers are grounded in this paper and cite their sources.
Associated with lower MACE in multivessel disease; hypothesis-generating and requires randomized confirmation before practice change.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Patrick W. Serruys (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: